Akeega

Prostate cancer: Three drug trials to watch
Clinical Trials Arena
Tue, 11/19/24 - 11:22 am
prostate cancer
clinical trials
Candel Therapeutics
ProstAtak
JNJ
Akeega
Pfizer
Mevrometostat
13 Therapies Make Clarivate’s 2024 Drugs to Watch List
BioSpace
Wed, 01/10/24 - 06:30 pm
Clarivate
Eylea
Tarpeyo/Kinpeygo
Dato-DXd
Altuviiio
RPL554
exa-cel
lovo-cel
LY-3074828
Akeega
Abrysvo
Talvey
Arexvy
IMAB362
J&J joins PARP rivals with narrow FDA clearance in prostate cancer
BioPharma Dive
Mon, 08/14/23 - 10:18 am
JNJ
Akeega
BRCA-mutated prostate cancer
PARP inhibitors
FDA
J&J claims first approval for PARP combo Akeega
Pharmaphorum
Mon, 04/24/23 - 10:22 am
JNJ
Janssen
Akeega
PARP inhibitors
metastatic castration-resistant prostate cancer
Europe
J&J wins EU backing for PARP combo Akeega in prostate cancer—but only in some patients
Fierce Pharma
Sun, 02/26/23 - 10:14 pm
JNJ
Akeega
prostate cancer
PARP inhibitors